EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

William J. Sandborn  ¹     Tadakazu Hisamatsu  ²     Kathleen Weisel  ³     Susana Gonzalez  ³     Mary Ellen Frustaci  ³     Zijiang Yang  ⁴     Jewel Johanns     Matthew Germinaro     Brian Feagan     Aniita Afzali     Walter Reinisch     Jane Andrews     Omoniyi J. Adedokun     Chenglong Han    
¹ University of California San Diego,San Diego,United States
² Kyorin University,Tokyo,Japan
³ Janssen Research & Development, LLC,Spring House,United States
⁴ Janssen Research & Development, LLC,S

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)